143 related articles for article (PubMed ID: 8781143)
1. Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity.
Ito K; Kato T; Ohta T; Tadokoro M; Yamada T; Ikeda M; Nishino M; Ishigaki T; Gambhir S
Eur J Nucl Med; 1996 Oct; 23(10):1372-7. PubMed ID: 8781143
[TBL] [Abstract][Full Text] [Related]
2. Recurrent rectal cancer and scar: differentiation with PET and MR imaging.
Ito K; Kato T; Tadokoro M; Ishiguchi T; Oshima M; Ishigaki T; Sakuma S
Radiology; 1992 Feb; 182(2):549-52. PubMed ID: 1732979
[TBL] [Abstract][Full Text] [Related]
3. [The value of positron emission tomography in the diagnosis of recurrent rectal cancer].
Lehner B; Schlag P; Strauss L; Dimitrakopoulou A; Herfarth C
Zentralbl Chir; 1990; 115(13):813-7. PubMed ID: 2238957
[TBL] [Abstract][Full Text] [Related]
4. Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging.
Keogan MT; Lowe VJ; Baker ME; McDermott VG; Lyerly HK; Coleman RE
Abdom Imaging; 1997; 22(3):332-7. PubMed ID: 9107663
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem.
Kato T; Fukatsu H; Ito K; Tadokoro M; Ota T; Ikeda M; Isomura T; Ito S; Nishino M; Ishigaki T
Eur J Nucl Med; 1995 Jan; 22(1):32-9. PubMed ID: 7698152
[TBL] [Abstract][Full Text] [Related]
6. Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy.
Schlag P; Lehner B; Strauss LG; Georgi P; Herfarth C
Arch Surg; 1989 Feb; 124(2):197-200. PubMed ID: 2783844
[TBL] [Abstract][Full Text] [Related]
7. PET scans of abdominal malignancy.
Blahd WH; Brown CV; Khonsary SA; Farahi JB; Quinones N; Ribe JY; Coyle JJ; Glass EC; Mandelkern MA
World J Surg; 1996 Feb; 20(2):245-7. PubMed ID: 8661826
[TBL] [Abstract][Full Text] [Related]
8. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
[TBL] [Abstract][Full Text] [Related]
9. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
10. FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
Pennings JP; de Haas RJ; Murshid KJA; de Jong KP; Dierckx RAJO; Kwee TC
Eur J Surg Oncol; 2019 Apr; 45(4):606-612. PubMed ID: 30594404
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
12. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
[TBL] [Abstract][Full Text] [Related]
13. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
Yuan CC; Liu RS; Wang PH; Ng HT; Yeh SH
J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
[TBL] [Abstract][Full Text] [Related]
14. A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Moore HG; Akhurst T; Larson SM; Minsky BD; Mazumdar M; Guillem JG
J Am Coll Surg; 2003 Jul; 197(1):22-8. PubMed ID: 12831920
[TBL] [Abstract][Full Text] [Related]
15. [Value of positron emission tomography (18F-FDG-PET) in the diagnosis of recurrent rectal cancer].
Franke J; Rosenzweig S; Reinartz P; Höer J; Kasperk R; Schumpelick V
Chirurg; 2000 Jan; 71(1):80-5. PubMed ID: 10663007
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of fusion images using (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography in local recurrence of rectal cancer.
Fukunaga H; Sekimoto M; Tatsumi M; Ikenaga M; Ohue M; Seshimo I; Higuchi I; Takayama O; Yasui M; Ikeda M; Yamamoto H; Monden M
Int J Oncol; 2002 Apr; 20(4):691-5. PubMed ID: 11894111
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine PET in detection of malignant tumors.
Inoue T; Kim EE; Wong FC; Yang DJ; Bassa P; Wong WH; Korkmaz M; Tansey W; Hicks K; Podoloff DA
J Nucl Med; 1996 Sep; 37(9):1472-6. PubMed ID: 8790196
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Harkness BA; Watson NE; Raben M; Frazier LC; Geisinger KR; Cappellari JO
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):841-5. PubMed ID: 8040032
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of the postoperative local recurrence of rectal cancer by FDG-PET--a case report].
Katsumoto Y; Maruyama N; Nakamura M; Shingai T; Maruyama K; Nakaguchi K; Furukawa J; Okajima S; Sue F; Fukunaga H; Ikenaga M; Sekimoto K
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1688-91. PubMed ID: 11708010
[TBL] [Abstract][Full Text] [Related]
20. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose.
Lapela M; Grénman R; Kurki T; Joensuu H; Leskinen S; Lindholm P; Haaparanta M; Ruotsalainen U; Minn H
Radiology; 1995 Oct; 197(1):205-11. PubMed ID: 7568825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
